ABSTRACT
A novel biosensor was prepared by using gold nanoparticles (AuNPs) signal amplification technology combined with liquid crystal biosensor to detect Cecropin B (CB). The surface of the substrate was modified with (3-aminopropyl)-triethoxysilane/N,N-dimethyl-N-octadecyl-(3-aminopropyl)-trimethoxysilyl chloride (APTES/DMOAP), glutaraldehyde (GA) as crosslinking, the AuNPs and Cecropin B antibody (anti-CB) complex could be fixed on the basal surface. CB and anti-CB can bind to make the liquid crystal (LC) changes in a vertical orientation, so as to achieve the purpose of testing. The volume of AuNPs is much larger than that of CB and anti-CB, thus AuNPs can play the role of signal amplification. Compared to the experiments without nano-gold amplification, our method has a lower detection limit. Finally, the limit of CB detection could be as low as 1.49 × 10−2 ng/mL. This method has the advantages of good specificity, high sensitivity, low detection limit and simple operation.
Graphical abstract
![](/cms/asset/28507b36-6966-4421-88be-1191539d7cfb/tlct_a_1729425_uf0001_oc.jpg)
Disclosure statement
No potential conflict of interest was reported by the authors.
Supplementary material
Supplemental data for this article can be accessed here.